Free Trial

Crescent Capital BDC (CCAP) Stock Price, News & Analysis

$17.96
-0.38 (-2.07%)
(As of 09/6/2024 ET)
Today's Range
$17.94
$18.40
50-Day Range
$17.47
$19.44
52-Week Range
$15.03
$19.63
Volume
90,292 shs
Average Volume
138,849 shs
Market Capitalization
$665.63 million
P/E Ratio
6.39
Dividend Yield
9.35%
Price Target
$18.80

Crescent Capital BDC MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
4.7% Upside
$18.80 Price Target
Short Interest
Healthy
0.23% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
-10.64%
From $2.35 to $2.10 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.56 out of 5 stars

Finance Sector

517th out of 871 stocks

Nondepository Credit Institutions Industry

24th out of 48 stocks

CCAP stock logo

About Crescent Capital BDC Stock (NASDAQ:CCAP)

Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

CCAP Stock Price History

CCAP Stock News Headlines

Why billionaires are wiring money to abandoned towns
A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution.
Crescent Capital BDC earnings: here's what Wall Street expects
Crescent Capital BDC Inc
Why billionaires are wiring money to abandoned towns
A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution.
3 Unheard of Dividend Stocks To Buy
See More Headlines
Receive CCAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Crescent Capital BDC and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/12/2024
Ex-Dividend for 9/16 Dividend
8/30/2024
Today
9/07/2024
Dividend Payable
9/16/2024
Ex-Dividend for 10/15 Dividend
9/30/2024
Dividend Payable
10/15/2024
Next Earnings (Estimated)
11/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Nondepository credit institutions
Sub-Industry
N/A
Current Symbol
NASDAQ:CCAP
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$18.80
High Stock Price Target
$19.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+4.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$83.84 million
Pretax Margin
46.12%

Debt

Sales & Book Value

Annual Sales
$111.11 million
Cash Flow
$2.04 per share
Book Value
$20.30 per share

Miscellaneous

Free Float
36,702,000
Market Cap
$665.63 million
Optionable
Not Optionable
Beta
0.81
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

CCAP Stock Analysis - Frequently Asked Questions

How have CCAP shares performed this year?

Crescent Capital BDC's stock was trading at $17.38 at the beginning of 2024. Since then, CCAP stock has increased by 3.3% and is now trading at $17.96.
View the best growth stocks for 2024 here
.

How were Crescent Capital BDC's earnings last quarter?

Crescent Capital BDC, Inc. (NASDAQ:CCAP) issued its earnings results on Monday, August, 12th. The company reported $0.59 EPS for the quarter, topping the consensus estimate of $0.58 by $0.01. The firm had revenue of $48.95 million for the quarter, compared to the consensus estimate of $48.05 million. Crescent Capital BDC had a trailing twelve-month return on equity of 12.03% and a net margin of 51.61%.

Who are Crescent Capital BDC's major shareholders?

Top institutional shareholders of Crescent Capital BDC include Sun Life Financial Inc. (4.97%), Millennium Management LLC (0.72%), Condor Capital Management (0.68%) and Sumitomo Mitsui Trust Holdings Inc. (0.22%). Insiders that own company stock include Jason Breaux, Joseph Hanlon, Gerhard Lombard, Raymond Barrios, Erik G Barrios, V Prem Et Al Watsa and Kirill Bouek.
View institutional ownership trends
.

How do I buy shares of Crescent Capital BDC?

Shares of CCAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Crescent Capital BDC own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Crescent Capital BDC investors own include NGL Energy Partners (NGL), Annaly Capital Management (NLY), Enterprise Products Partners (EPD), Macerich (MAC), OFS Capital (OFS), AGNC Investment (AGNC) and Chimera Investment (CIM).

This page (NASDAQ:CCAP) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners